Then, combined with mechanistic studies, it jointly revealed that loss of function of FAT1 could activate a CAMK2-CD44-SRC axis to promote tumor initiation, progression, invasiveness, stemness, and metastasis (75). The gene discussed is SRC; the disease is neoplasm.